Literature DB >> 19944361

Post-exercise heart rate recovery independently predicts mortality risk in patients with chronic heart failure.

Yi-Da Tang1, Thomas A Dewland, Detlef Wencker, Stuart D Katz.   

Abstract

BACKGROUND: Post-exercise heart rate recovery (HRR) is an index of parasympathetic function associated with clinical outcomes in populations with and without documented coronary heart disease. Decreased parasympathetic activity is thought to be associated with disease progression in chronic heart failure (HF), but an independent association between post-exercise HRR and clinical outcomes among such patients has not been established. METHODS AND
RESULTS: We measured HRR (calculated as the difference between heart rate at peak exercise and after 1 minute of recovery) in 202 HF subjects and recorded 17 mortality and 15 urgent transplantation outcome events over 624 days of follow-up. Reduced post-exercise HRR was independently associated with increased event risk after adjusting for other exercise-derived variables (peak oxygen uptake and change in minute ventilation per change in carbon dioxide production slope), for the Heart Failure Survival Score (adjusted HR 1.09 for 1 beat/min reduction, 95% CI 1.05-1.13, P < .0001), and the Seattle Heart Failure Model score (adjusted HR 1.08 for one beat/min reduction, 95% CI 1.05-1.12, P < .0001). Subjects in the lowest risk tertile based on post-exercise HRR (>or=30 beats/min) had low risk of events irrespective of the risk predicted by the survival scores. In a subgroup of 15 subjects, reduced post-exercise HRR was associated with increased serum markers of inflammation (interleukin-6, r = 0.58, P = .024; high-sensitivity C-reactive protein, r = 0.66, P = .007).
CONCLUSIONS: Post-exercise HRR predicts mortality risk in patients with HF and provides prognostic information independent of previously described survival models. Pathophysiologic links between autonomic function and inflammation may be mediators of this association.

Entities:  

Mesh:

Year:  2009        PMID: 19944361      PMCID: PMC2786814          DOI: 10.1016/j.cardfail.2009.06.437

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  43 in total

1.  Prognostic value of heart rate recovery in patients with heart failure.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2006-04       Impact factor: 4.749

2.  The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.

Authors:  Michael J Lipinski; George W Vetrovec; Dmitry Gorelik; Victor F Froelicher
Journal:  J Card Fail       Date:  2005-10       Impact factor: 5.712

3.  Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.

Authors:  Thomas A Dewland; Ana Silvia Androne; Forrester A Lee; Rachel J Lampert; Stuart D Katz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-23       Impact factor: 4.733

4.  Early heart rate recovery after exercise predicts mortality in patients with chronic heart failure.

Authors:  Serafim Nanas; Maria Anastasiou-Nana; Stavros Dimopoulos; Dimitrios Sakellariou; George Alexopoulos; Smaragdo Kapsimalakou; Panagiotis Papazoglou; Elias Tsolakis; Ourania Papazachou; Charis Roussos; John Nanas
Journal:  Int J Cardiol       Date:  2005-12-20       Impact factor: 4.164

5.  Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.

Authors:  Anselm K Gitt; Karlman Wasserman; Caroline Kilkowski; Thomas Kleemann; Andreas Kilkowski; Matthias Bangert; Steffen Schneider; Armin Schwarz; Jochen Senges
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

6.  Heart-rate recovery immediately after exercise as a predictor of mortality.

Authors:  C R Cole; E H Blackstone; F J Pashkow; C E Snader; M S Lauer
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

7.  Cardiac parasympathetic regulation: respective associations with cardiorespiratory fitness and training load.

Authors:  Martin Buchheit; Cyrille Gindre
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02-24       Impact factor: 4.733

8.  C-reactive protein in heart failure: prognostic value and the effect of valsartan.

Authors:  Inder S Anand; Roberto Latini; Viorel G Florea; Michael A Kuskowski; Thomas Rector; Serge Masson; Stefano Signorini; Paolo Mocarelli; Allen Hester; Robert Glazer; Jay N Cohn
Journal:  Circulation       Date:  2005-08-29       Impact factor: 29.690

9.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

10.  Independent relationship between heart rate recovery and C-reactive protein in older adults.

Authors:  Victoria J Vieira; Rudy J Valentine; Edward McAuley; Ellen Evans; Jeffrey A Woods
Journal:  J Am Geriatr Soc       Date:  2007-05       Impact factor: 5.562

View more
  20 in total

1.  Does an acute inflammatory response temporarily attenuate parasympathetic reactivation?

Authors:  Sae Young Jae; Kevin S Heffernan; Soo-Hyun Park; Sun-Hae Jung; Eun Sun Yoon; Euy Jin Kim; Eui Soo Ahn; Bo Fernhall
Journal:  Clin Auton Res       Date:  2010-05-01       Impact factor: 4.435

2.  In search of the optimal measure for assessment of parasympathetic control of heart rate.

Authors:  Stuart D Katz
Journal:  Clin Auton Res       Date:  2010-02       Impact factor: 4.435

3.  Multi-scale heart rate dynamics detected by phase-rectified signal averaging predicts mortality after acute myocardial infarction.

Authors:  Masaya Kisohara; Phyllis K Stein; Yutaka Yoshida; Mari Suzuki; Narushi Iizuka; Robert M Carney; Lana L Watkins; Kenneth E Freedland; James A Blumenthal; Junichiro Hayano
Journal:  Europace       Date:  2012-12-17       Impact factor: 5.214

4.  Exercise heart rates in patients with hypertrophic cardiomyopathy.

Authors:  Hong-Chang Luo; Veronica L Dimaano; Jackelyn M Kembro; Alex Hilser; David Hurtado-de-Mendoza; Iraklis Pozios; Miguel S Tomas; Hulya Yalcin; Ketty Dolores-Cerna; Wilfredo Mormontoy; Miguel A Aon; Duke Cameron; David A Bluemke; Kerry J Stewart; Stuart D Russell; Jorge G Cordova; Theodore P Abraham; M Roselle Abraham
Journal:  Am J Cardiol       Date:  2015-02-04       Impact factor: 2.778

5.  Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis.

Authors:  M J Pearson; N A Smart
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 6.  Methods of assessing vagus nerve activity and reflexes.

Authors:  Mark W Chapleau; Rasna Sabharwal
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

7.  Progressive chronic heart failure slows the recovery of microvascular O2 pressures after contractions in the rat spinotrapezius muscle.

Authors:  Steven W Copp; Daniel M Hirai; Leonardo F Ferreira; David C Poole; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-03       Impact factor: 4.733

8.  Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.

Authors:  Duc Ha; Kevin Stephans; Humberto Choi; Katrina Zell; Xiao-Feng Wang; Omar A Minai; Daniel P Raymond; Gregory Videtic; Peter J Mazzone
Journal:  J Radiosurg SBRT       Date:  2015

9.  Oxygen Kinetics and Heart Rate Response during Early Recovery from Exercise in Patients with Heart Failure.

Authors:  Charalampos D Kriatselis; Sotirios Nedios; Sebastian Kelle; Sebastian Helbig; Martin Gottwik; Christian von Bary
Journal:  Cardiol Res Pract       Date:  2012-01-24       Impact factor: 1.866

10.  RGS Proteins in Heart: Brakes on the Vagus.

Authors:  Adele Stewart; Jie Huang; Rory A Fisher
Journal:  Front Physiol       Date:  2012-04-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.